Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
UMotif is a scalable and engaging patient-centred data capture platform for modern research.
Regulatory Genome provides machine-readable regulatory content to increase accessibility and dissemination of information.
NuvoAir is a value-based specialty management platform transforming the diagnosis and management of chronic heart and lung conditions.
Brytlyt provides transformational serverless acceleration for analytics
The Limitless GigCX platform enables businesses to connect customers with qualified experts to solve customer service enquiries on-demand.
Credit Kudos is a credit bureau that uses financial behavior and data through open banking to measure creditworthiness.
Clear Review is a continuous performance management and engagement system.
Astroscreen protects brands and defends democracy from harmful social media manipulation campaigns also known as astroturfing.
Xperiome is a global healthtech company that delivers deep insights in rare disease experiences
My Meds & Me provides a web-based solution for the capture of adverse event, product complaint.
AlbionVC has invested in 82 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
AlbionVC's top investment sectors include Health Care, Medical, Software, Artificial Intelligence (AI), Data Visualization. The firm invests across 25 different industry categories.
Among tracked funding rounds, uMotif received $25.2M in a Series B round. AlbionVC's total known invested capital is $1.3B.
AlbionVC's average investment size is $16.0M across its portfolio of 82 companies.
Recent AlbionVC portfolio additions include uMotif, Regulatory Genome, NuvoAir, brytlyt, Limitless. These companies were founded in 2020 or later.